378 related articles for article (PubMed ID: 27436311)
1. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles.
Falsini S; Ristori S
Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311
[TBL] [Abstract][Full Text] [Related]
2. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes.
de la Torre LG; Rosada RS; Trombone AP; Frantz FG; Coelho-Castelo AA; Silva CL; Santana MH
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):175-84. PubMed ID: 19540734
[TBL] [Abstract][Full Text] [Related]
3. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting DNA binding and stability of association to cationic liposomes.
Even-Chen S; Cohen R; Barenholz Y
Chem Phys Lipids; 2012 May; 165(4):414-23. PubMed ID: 22715503
[TBL] [Abstract][Full Text] [Related]
5. Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes.
Remaut K; Sanders NN; Fayazpour F; Demeester J; De Smedt SC
J Control Release; 2006 Oct; 115(3):335-43. PubMed ID: 17010468
[TBL] [Abstract][Full Text] [Related]
6. Transfection of plasmid DNA by nanocarriers containing a gemini cationic lipid with an aromatic spacer or its monomeric counterpart.
Martínez-Negro M; Barrán-Berdón AL; Aicart-Ramos C; Moyá ML; de Ilarduya CT; Aicart E; Junquera E
Colloids Surf B Biointerfaces; 2018 Jan; 161():519-527. PubMed ID: 29128838
[TBL] [Abstract][Full Text] [Related]
7. Effect of "helper lipid" on lipoplex electrostatics.
Hirsch-Lerner D; Zhang M; Eliyahu H; Ferrari ME; Wheeler CJ; Barenholz Y
Biochim Biophys Acta; 2005 Aug; 1714(2):71-84. PubMed ID: 16051183
[TBL] [Abstract][Full Text] [Related]
8. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
9. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids.
Even-Chen S; Barenholz Y
Biochim Biophys Acta; 2000 Dec; 1509(1-2):176-88. PubMed ID: 11118529
[TBL] [Abstract][Full Text] [Related]
10. Polyethylene glycol enhances lipoplex-cell association and lipofection.
Ross PC; Hui SW
Biochim Biophys Acta; 1999 Oct; 1421(2):273-83. PubMed ID: 10518697
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology.
Schuh RS; Poletto É; Fachel FNS; Matte U; Baldo G; Teixeira HF
J Colloid Interface Sci; 2018 Nov; 530():243-255. PubMed ID: 29982016
[TBL] [Abstract][Full Text] [Related]
12. Ca(2+)-mediated anionic lipid-plasmid DNA lipoplexes. Electrochemical, structural, and biochemical studies.
Barrán-Berdón AL; Yélamos B; Malfois M; Aicart E; Junquera E
Langmuir; 2014 Oct; 30(39):11704-13. PubMed ID: 25211646
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the physicochemical and structural properties of pDNA/cationic liposome complexes with their in vitro transfection.
Balbino TA; Gasperini AA; Oliveira CL; Azzoni AR; Cavalcanti LP; de La Torre LG
Langmuir; 2012 Aug; 28(31):11535-45. PubMed ID: 22788539
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9.
Hosseini ES; Nikkhah M; Hosseinkhani S
Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265
[No Abstract] [Full Text] [Related]
15. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
17. The biological activity of cationic liposomes in drug delivery and toxicity test in animal models.
Qi P; Cao M; Song L; Chen C; Liu M; Li N; Wu D; Peng J; Hu G; Zhao J
Environ Toxicol Pharmacol; 2016 Oct; 47():159-164. PubMed ID: 27694054
[TBL] [Abstract][Full Text] [Related]
18. DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes.
Kim BK; Hwang GB; Seu YB; Choi JS; Jin KS; Doh KO
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):1996-2001. PubMed ID: 26112463
[TBL] [Abstract][Full Text] [Related]
19. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.
Barichello JM; Ishida T; Kiwada H
Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901
[TBL] [Abstract][Full Text] [Related]
20. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
